|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
|---|---|
| Information provided by: | Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
| ClinicalTrials.gov Identifier: | NCT00825981 |
Purpose
Patients undergoing elective coronary artery bypass graft surgery (CABG) are treated with platelet inhibitors to reduce myocardial infarction and mortality.However, this can increase perioperative bleeding. A retrospective analysis of the data in our institution has revealed a significant increase in transfusion requirements after elective CABG since 5 years. The aim of our study is to observe if this increase in transfusion requirements is due to platelet inhibitors or due to other coagulation abnormalities resulting from other anticoagulants.
| Condition | Intervention |
|---|---|
|
Coronary Disease |
Other: screening coagulation abnormalities |
| Study Type: | Observational |
| Study Design: | Cohort, Prospective |
| Estimated Enrollment: | 100 |
| Study Start Date: | January 2009 |
| Estimated Study Completion Date: | March 2010 |
| Estimated Primary Completion Date: | January 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
coronary artery bypass graft
patients undergoing elective coronary artery bypass graft with or without cardiopulmonary bypass
|
Other: screening coagulation abnormalities
if specific coagulation abnormalities are observed which increase patient's risk of bleeding, appropriate treatment will start
|
Eligibility| Ages Eligible for Study: | 18 Years to 90 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
coronary artery bypass graft
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: MONA MOMENI, MD | +32.2764.7029 | mona.momeni@uclouvain.be |
| Belgium | |
| Cliniques Universitaires Saint Luc | Recruiting |
| Brussels, Belgium, 1200 | |
| Contact: MONA MOMENI, MD +32.2764.7029 mona.momeni@uclouvain.be | |
| Principal Investigator: MONA MOMENI, MD | |
More Information
| Responsible Party: | Cliniques Universitaires saint Luc ( Mona Momeni, MD ) |
| Study ID Numbers: | 2008/10DEC/350 |
| Study First Received: | January 16, 2009 |
| Last Updated: | January 20, 2009 |
| ClinicalTrials.gov Identifier: | NCT00825981 History of Changes |
| Health Authority: | Belgium: Institutional Review Board |
|
Arterial Occlusive Diseases Coronary Disease Heart Diseases Myocardial Ischemia Vascular Diseases |
Neoplasm Metastasis Arteriosclerosis Ischemia Hemostatics Coronary Artery Disease |
|
Arterial Occlusive Diseases Coronary Disease Heart Diseases Myocardial Ischemia |
Vascular Diseases Cardiovascular Diseases Arteriosclerosis Coronary Artery Disease |
